Management of advanced breast cancer with the epothilone B analog, ixabepilone
William GradisharRobert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USAAbstract: Despite the activity of standard chemotherapies in advanced breast cancer, disease progression remains inevitable. Most patients exposed to anthracyclines and t...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-06-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/management-of-advanced-breast-cancer-with-the-epothilone-b-analog-ixab-a3225 |